What Consistently High-Enrolling Sites Do Differently

Across a few hundred sites, enrollment performance clusters. A small group consistently delivers above target, a large middle hits roughly half, and a tail struggles. The gap is rarely about geography or patient population — most high enrollers work in ordinary markets with ordinary databases. What separates them is a set of operating habits anyone can copy.

They treat recruitment as a standing function, not a campaign

Low-performing sites recruit in bursts: a study activates, panic sets in, ads go up, the budget burns, enrollment closes. High enrollers keep a continuous pipeline. They run condition-specific interest lists year-round — diabetes, migraine, COPD, whatever their therapeutic focus is — so when a protocol activates they're calling warm contacts in week one instead of buying cold traffic in week six.

Practically, this means someone owns recruitment on the org chart. Not "the coordinator who has time." A named person with weekly metrics and the authority to change course mid-study.

They know their funnel numbers cold

Ask a high-performing site director what percentage of phone pre-screens convert to screening visits, and you'll get an answer within a few points. Ask a struggling site and you'll get an estimate.

The minimum set worth tracking per study:

• Inbound inquiries by source
• Pre-screen attempt-to-contact rate
• Pre-screen pass rate
• Scheduled-to-attended visit rate
• Screen-to-randomize rate

These five numbers tell you where to intervene. A low pass rate means your advertising is targeting the wrong people. A low attended rate means your scheduling or reminder process is leaking. Sites that don't measure this tend to default to "we need more leads," which is usually the most expensive possible fix.

They staff the first 72 hours after an inquiry

In most site datasets, contact rates drop sharply once a lead sits more than a day. High enrollers build coverage around that window — early-morning and evening call blocks, a second caller when volume spikes, text as the opening touch rather than voicemail. They also set a call-attempt floor, commonly five or six attempts across different times of day before a lead is retired. Struggling sites often stop at two.

They say no to protocols they can't fill

Counterintuitively, the highest enrollers decline more studies. They run honest feasibility against their actual chart counts and their current staff bandwidth, and they pass when the math doesn't work. That protects the thing sponsors watch most closely: your history of hitting commitments. A site with six studies at 100% of target gets better allocations than a site with fifteen studies at 40%.

They debrief every screen failure and every dropout

High enrollers run a short weekly review — fifteen minutes — on everyone who didn't make it through. Patterns surface fast: an exclusion criterion that's disqualifying half of eligible-looking candidates, a lab draw scheduled at an impossible time, a consent conversation that's losing people at the randomization discussion. Each pattern turns into a protocol amendment request, a scheduling change, or a script revision.

They invest in the referral network between studies

Referring physicians don't respond to cold outreach during enrollment crunches. High enrollers send outcome letters back on every referred patient, show up at department meetings when they have nothing to ask for, and keep a one-page list of currently enrolling studies in front of the people who see those patients daily.

None of this is exotic. It's ownership, measurement, speed, and selectivity — applied consistently rather than in response to a sponsor escalation call.